Results for tag: "Varubi"

Varubi (rolapitant) is a prescription medication used to prevent nausea and vomiting caused by chemotherapy in adults. It is a neurokinin-1 (NK-1) receptor antagonist, which works by blocking the action of a chemical messenger in the brain that can cause nausea and vomiting. Varubi is approved by the U.S. Food and Drug Administration (FDA) for use in combination with other antiemetic medications. The Varubi market is a subset of the larger oncology drugs market, which includes medications used to treat cancer and its symptoms. Oncology drugs are typically used in combination with other treatments such as surgery, radiation, and chemotherapy. The global oncology drugs market is expected to grow at a steady rate due to the increasing prevalence of cancer and the development of new treatments. Some companies in the Varubi market include Merck & Co., Inc., Teva Pharmaceuticals, and Sun Pharmaceutical Industries Ltd. Show Less Read more